COMMUNIQUÉS West-GlobeNewswire

Novartis to showcase transformative data in advanced prostate and early breast cancer at ESMO 2025
26/09/2025
Key data from PSMAddition has been selected for a Presidential session; data to showcase the efficacy and safety of Pluvicto TM plus standard of care (SoC) versus SoC alone in PSMA+ mHSPC NATALEE five-year analysis of [...]
Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs
26/09/2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reiterated that its allogeneic cell therapy products [...]
Ipsen et BioLabs Hôtel-Dieu décernent le Golden Ticket Ipsen 2025 à DETERA Therapeutics
26/09/2025
Paris, le 26 septembre 2025 – BioLabs Hôtel-Dieu, en partenariat avec Ipsen, annoncent aujourd'hui que DETERA Therapeutics s'est vu décerner le Golden Ticket Ipsen 2025 . Ce prix offre un an d'accès gratuit à un [...]
Fangzhou’s ‘XingShi’ LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care
26/09/2025
SHANGHAI, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, announced that its “XingShi” Large Language Model (“XS LLM”) was [...]
Concept Life Sciences Expands Integrated Drug Discovery Facilities
26/09/2025
Establishes one of the UK’s largest drug discovery research sites Site officially opened by local MP Jonathan Pearce CHAPEL-EN-LE-FRITH, United Kingdom, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Concept Life Sciences, a [...]
uniQure Announces Pricing of Upsized $300 Million Public Offering
26/09/2025
LEXINGTON, Mass. and AMSTERDAM, Sept. 25, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced [...]
OSE Immunotherapeutics, Inserm Transfert et Nantes Université annoncent un partenariat stratégique pour accélérer l’innovation en immunothérapie
26/09/2025
OSE Immunotherapeutics, Inserm Transfert et Nantes Université annoncent un partenariat stratégique pour accélérer l’innovation en immunothérapie Nantes, le 26 septembre 2025, 7 heures – OSE Immunotherapeutics SA ( ISIN [...]
OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy
26/09/2025
OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy NANTES, France – September 26, 2025, 7:00 a.m. – OSE Immunotherapeutics SA (ISIN: [...]
Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025
26/09/2025
Geneva, Switzerland, September 26, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for [...]
Grant of Restricted Stock Units and Warrants to Employees in Genmab
26/09/2025
Company Announcement COPENHAGEN, Denmark; September 26, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 14,353 restricted stock units and 9,681 warrants to employees of the [...]
Harrow Launches Harrow Access for All (HAFA)
25/09/2025
HAFA to Expand Harrow’s Innovative Market Access Model Across Ophthalmic Portfolio Program will be available in late 2025 through the HarrowAccess.com Portal NASHVILLE, Tenn., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Harrow ( [...]
CapsoVision to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
25/09/2025
SARATOGA, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced [...]
LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
25/09/2025
NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the ROTH 4 th Annual Healthcare Opportunities [...]
Medtimo Files Patent Infringement Complaint Against Allurion Technologies
25/09/2025
Complaint Seeks to Protect Medtimo’s Balloon System Technology and Alleges That Allurion Infringes Three Medtimo Patents IRVINE, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Medtimo Inc , a wholly owned subsidiary of [...]
Buying Guide 2025- most effective female libido booster pills in 2025 By OhYes
25/09/2025
When it comes to the best pill for enhancing a woman's sex life, the answer is simple: Oh Yes. This American-made supplement is packed with some of the most effective, all-natural libido-boosting ingredients available, [...]
Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025
25/09/2025
TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter 2025 financial results on Wednesday [...]
Teva Releases Q3 2025 Aide Memoire
25/09/2025
TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q3 2025 Aide Memoire is available on the “Investors” page on its website. Q3 2025 [...]
Organogenesis Provides Update on Second Phase 3 ReNu® Study
25/09/2025
Company maintains confidence in ReNu as innovative pain management therapy Second Phase 3 trial demonstrates numerical improvement in baseline pain reduction over the first Phase 3 trial despite not meeting the primary [...]
Medicenna Announces Results of Annual Meeting of Shareholders
25/09/2025
TORONTO and HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of [...]

Pages